Vaccinomics: a cross-sectional survey of public values
Objective: We characterize public values regarding vaccinomics, which aims to improve vaccine safety and effectiveness using genomics. Methods: Panel survey (2020) of ≥18-year-olds with embedded animation introduced vaccinomics. Sociodemographic, health, and vaccination-related items were adapted fr...
Päätekijät: | Jennifer E. Gerber, Janesse Brewer, Rupali J. Limaye, Andrea Sutherland, Madeleine Blunt, Taylor A. Holroyd, Gail Geller, Bruce Carleton, Jeffery Kahn, Daniel A. Salmon |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Taylor & Francis Group
2021-09-01
|
Sarja: | Human Vaccines & Immunotherapeutics |
Aiheet: | |
Linkit: | http://dx.doi.org/10.1080/21645515.2021.1911217 |
Samankaltaisia teoksia
-
Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics
Tekijä: Alessandra Ferraresi, et al.
Julkaistu: (2022-12-01) -
Ethical and policy implications of vaccinomics in the United States: community members’ perspectives
Tekijä: Jennifer E. Gerber, et al.
Julkaistu: (2021-07-01) -
TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines
Tekijä: Federico Martinón-Torres, et al.
Julkaistu: (2019-10-01) -
Universal peptide-based potential vaccine design against canine distemper virus (CDV) using a vaccinomic approach
Tekijä: Santiago Rendon-Marin, et al.
Julkaistu: (2024-07-01) -
Advanced vaccinomic, immunoinformatic, and molecular modeling strategies for designing Multi- epitope vaccines against the Enterobacter cloacae complex
Tekijä: Hassan H. Alhassan
Julkaistu: (2024-08-01)